Abstract
In this examination of 104 large patient-advocacy organizations, 83% receive financial support from drug, device, and biotechnology companies, and industry executives often serve on governing boards. The authors recommend more transparency about industry involvement.
Cite
CITATION STYLE
APA
McCoy, M. S., Carniol, M., Chockley, K., Urwin, J. W., Emanuel, E. J., & Schmidt, H. (2017). Conflicts of Interest for Patient-Advocacy Organizations. New England Journal of Medicine, 376(9), 880–885. https://doi.org/10.1056/nejmsr1610625
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free